Assetmark Inc. boosted its stake in Rentokil Initial PLC (NYSE:RTO – Free Report) by 28.2% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 468,513 shares of the company’s stock after buying an additional 103,011 shares during the period. Assetmark Inc. owned 0.09% of Rentokil Initial worth $11,830,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors also recently modified their holdings of the company. Jane Street Group LLC grew its position in shares of Rentokil Initial by 292.0% during the first quarter. Jane Street Group LLC now owns 117,341 shares of the company’s stock worth $2,687,000 after acquiring an additional 87,405 shares during the last quarter. IFP Advisors Inc boosted its stake in Rentokil Initial by 115.5% during the 2nd quarter. IFP Advisors Inc now owns 1,282 shares of the company’s stock valued at $31,000 after purchasing an additional 687 shares during the period. Vanguard Personalized Indexing Management LLC bought a new position in Rentokil Initial in the 2nd quarter worth about $317,000. Exencial Wealth Advisors LLC grew its position in Rentokil Initial by 6.5% in the 2nd quarter. Exencial Wealth Advisors LLC now owns 47,919 shares of the company’s stock worth $1,150,000 after purchasing an additional 2,934 shares during the last quarter. Finally, Ethic Inc. acquired a new stake in shares of Rentokil Initial in the second quarter valued at approximately $212,000. Institutional investors and hedge funds own 9.91% of the company’s stock.
Analysts Set New Price Targets
RTO has been the subject of several analyst reports. Rothschild & Co Redburn downgraded Rentokil Initial from a “hold” rating to a “strong sell” rating in a research report on Friday, January 30th. Bank of America upgraded Rentokil Initial from a “neutral” rating to a “buy” rating and set a $34.00 price target for the company in a research report on Thursday, December 18th. JPMorgan Chase & Co. reissued an “overweight” rating on shares of Rentokil Initial in a research note on Friday, November 21st. Morgan Stanley upgraded shares of Rentokil Initial from an “equal weight” rating to an “overweight” rating in a research note on Tuesday, January 6th. Finally, Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Rentokil Initial in a report on Thursday, January 22nd. One investment analyst has rated the stock with a Strong Buy rating, five have given a Buy rating, two have assigned a Hold rating and two have given a Sell rating to the company’s stock. According to MarketBeat, Rentokil Initial presently has a consensus rating of “Moderate Buy” and an average price target of $34.00.
Rentokil Initial Stock Up 0.5%
Shares of RTO stock opened at $30.43 on Monday. Rentokil Initial PLC has a 1 year low of $19.60 and a 1 year high of $33.46. The company has a current ratio of 1.12, a quick ratio of 1.03 and a debt-to-equity ratio of 0.79. The business’s fifty day moving average is $30.84 and its 200-day moving average is $27.71.
Rentokil Initial Company Profile
Rentokil Initial PLC is a global business services company specializing in pest control, hygiene and workwear services. Headquartered in Crawley, West Sussex, United Kingdom, the company delivers outsourced solutions designed to protect people, preserve assets and enhance workplaces for both commercial and residential customers.
Under the Rentokil Pest Control brand, the company offers services ranging from routine inspections and treatment of insects, rodents and birds to specialised programmes for food manufacturing and healthcare environments.
Further Reading
- Five stocks we like better than Rentokil Initial
- This $15 Stock Could Go Down as the #1 Stock of 2026
- I’m 70 With $1.5M: Would Converting $120K a Year to a Roth Be Smart or a Costly Mistake? (Ask An Advisor)
- America’s 1776 happening again
- Trump & Musk’s Secret Bet on Silver — Exposed
- URGENT: Sell this stock immediately
Receive News & Ratings for Rentokil Initial Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rentokil Initial and related companies with MarketBeat.com's FREE daily email newsletter.
